AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Global Hydronephrosis Therapies Market 2019-2023 | High Prevalence of Kidney Diseases Impacting the Market Growth | Technavio

November 20, 2018

LONDON--(BUSINESS WIRE)--Nov 20, 2018--The global hydronephrosis therapies market 2019-2023 is expected to post a CAGR of more than 9% during the forecast period, according to the latest market research report by .

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005494/en/

Technavio predicts the global hydronephrosis therapies market to post a CAGR of more than 9% by 2023. (Graphic: Business Wire)

A key factor driving the growth of the market is the high prevalence of kidney diseases. Hydronephrosis is caused by kidney diseases such as UTIs, CKD, and kidney stones. CKD is the most common type of kidney disease which causes inflammation and swelling of the kidney. According to the CDC, around 30 million people or 15% of the US adults are estimated to have CKD and 48% of those with severely reduced kidney function but not on dialysis are not aware of having CKD. Thus, the increase in the prevalence of the kidney diseases results in the growing prevalence of hydronephrosis.

This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only:

In this report, Technavio highlights the increasing awareness of kidney diseases as one of the key emerging trends in the global hydronephrosis therapies market:

Global hydronephrosis therapies market: Increasing awareness of kidney diseases

Kidney diseases are the major causes of hydronephrosis. However, early-stage kidney disease is typically asymptomatic and may not notice any symptoms, which, in turn, leads to low levels of awareness in people with CKD. Thus, with the aim of addressing this issue, various government and non-government organizations are launching various awareness programs which is driving the market.

“In 2006, the CDC established the CKD initiative to raise the awareness and making collaborations with universities for the management of kidney diseases. The increase in number of these initiatives will drive the global hydronephrosis therapies market,” says a senior analyst at Technavio for research on infectious and rare diseases.

Global hydronephrosis therapies market: Segmentation analysis

This market research report segments the global hydronephrosis therapies market by product (antibiotic therapy and other therapies) and geographical regions (APAC, EMEA, and the Americas).

The Americas led the market in 2018 with a market share of more than 42%, followed by EMEA and APAC respectively. The dominance of the Americas can be attributed to the factors such as the rising geriatric population and recent approvals for the treatment of UTIs.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20181120005494/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 11/20/2018 10:29 AM/DISC: 11/20/2018 10:29 AM

http://www.businesswire.com/news/home/20181120005494/en